Jun SHAO
Jun SHAO is a Series A investor at CAS Investment Management focused on Medical and Biopharma. Jun SHAO
- Total investments:
- 1
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jun SHAO invests in
Stages Jun SHAO invests in
Countries Jun SHAO invests in
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Artificial Intelligence 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Phil Rivers Technology
|
Zheyuan Technology is an AI pharmaceutical R&D solution provider. | $14.2M / Series A |
Co-Investors
ChemPartner
1 deal together
About CAS Investment Management
CAS Investment Management Co., Ltd. (abbreviated as CASI)' s controlling shareholder is Chinese Academy of Sciences Holdings Co., Ltd. (CAS Holdings www.casholdings.com.cn ) and has State-owned Assets Supervision and Administration Commission of the State Council (SASAC http://www.sasac.gov.cn/n1180/index.html ) and anemployee-owned company as shareholders. Its predecessor is the Chinese National Economic Council-CAS Scientific and Technological Promotion & Economic Development Foundation.With a mission of “providing capital support and value-added service to industrial leaders, and promoting them to be outstanding companies with international competitiveness”, CASI is dedicated to be a Chinese leading PE fund manager.
CAS Investment Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jun SHAO
CFO
|
|||
Qianhong LIU
CEO
|
|||
|
Sun Hua
Chairman
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jun SHAO invest in?
Jun SHAO invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
